Search Results

You are looking at 21 - 30 of 46 items for :

  • "polycystic ovarian syndrome" x
  • Refine by Access: All content x
Clear All
Open access

Thomas Reinehr, Alberto Sánchez-Guijo, Nina Lass, and Stefan A Wudy

mellitus, lipid abnormalities and hypertension and may therefore be at particular risk of developing atherosclerotic complications ( 2 , 5 , 6 , 7 , 8 , 9 ). Furthermore, increased androgens are related to polycystic ovarian syndrome (PCOS) in females

Open access

Teresa Vilariño-García, Antonio Pérez-Pérez, Esther Santamaría-López, Nicolás Prados, Manuel Fernández-Sánchez, and Víctor Sánchez-Margalet

fertile patients with polycystic ovarian syndrome . Journal of Clinical Endocrinology and Metabolism 2007 92 4771 – 4776 . ( ) 25 Daan NMP Louwers YV Koster MPH Eijkemans MJC Rijke YB de Lentjes EWG

Open access

Sweta Budyal, Swati Sachin Jadhav, Rajeev Kasaliwal, Hiren Patt, Shruti Khare, Vyankatesh Shivane, Anurag R Lila, Tushar Bandgar, and Nalini S Shah

with type 2 diabetes mellitus (T2DM), obesity, osteoporosis, and polycystic ovarian syndrome (PCOS) (4, 5, 6, 7, 8) . As impaired glucose tolerance and diabetes are important metabolic manifestations of CS, several studies have attempted to examine the

Open access

Anette Lundqvist, Herbert Sandström, and Torbjörn Bäckström

more energy-rich food over more palatable food ( 21 ), which increased their weight after a short exposure time ( 22 ). Allopregnanolone also relates to uncontrolled eating in women with polycystic ovarian syndrome ( 23 ) – a condition with high

Open access

Hui Long, Yanhong Nie, Li Wang, Yong Lu, Yan Wang, Yijun Cai, Zhen Liu, Miaomiao Jia, Qifeng Lyu, Yanping Kuang, and Qiang Sun

.1371/journal.pone.0068223 ) 10.1371/journal.pone.0068223 24023708 28 Teede HJ Norman R . Polycystic ovarian syndrome: insights into the enigma that is PCOS today . Endocrine 2006 30 1 – 2 . ( ) 10.1385/ENDO:30

Open access

Nicolás Crisosto, Bárbara Echiburú, Manuel Maliqueo, Marta Luchsinger, Pedro Rojas, Sergio Recabarren, and Teresa Sir-Petermann

Magnus P Sandvik L Høglo S . Familial clustering in the polycystic ovarian syndrome. Gynecologic and Obstetric Investigation 1989 28 23 – 30 . ( doi:10.1159/000293493 ) 10.1159/000293493 2777131 7 Azziz R Carmina E Chen Z

Open access

Lina S Silva-Bermudez, Freddy J K Toloza, Maria C Perez-Matos, Russell J de Souza, Laura Banfield, Andrea Vargas-Villanueva, and Carlos O Mendivil

-Aubaidy HA A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome . Diabetes and Metabolic Syndrome 2016 10 (Supplement 1) S95 – S 98 . ( https

Open access

Xue-Lian Zhang, Xinyi Zhao, Yong Wu, Wen-qing Huang, Jun-jiang Chen, Peijie Hu, Wei Liu, Yi-Wen Chen, Jin Hao, Rong-Rong Xie, Hsiao Chang Chan, Ye Chun Ruan, Hui Chen, and Jinghui Guo

Diao FY Yu MK Liu JY Ruan YC Chan HC . Abnormal CFTR affects glucagon production by islet alpha cells in cystic fibrosis and polycystic ovarian syndrome . Frontiers in Physiology 2017 8 835. ( ) 24

Open access

Malin Nylander, Signe Frøssing, Caroline Kistorp, Jens Faber, and Sven O Skouby

. Comprehensive assessment of the hemostatic system in polycystic ovarian syndrome . Seminars in Thrombosis and Hemostasis 2016 42 55 – 62 . ( doi:10.1055/s-0035-1564837 ) 17 Aziz M Sidelmann JJ Wissing MLM Faber J Skouby SO

Open access

Krzysztof C Lewandowski, Justyna Płusajska, Wojciech Horzelski, Ewa Bieniek, and Andrzej Lewiński

Introduction The term ‘polycystic ovarian syndrome’ (PCOS) represents a heterogeneous and multifaceted entity characterised by hyperandrogenism and/or ovulatory dysfunction. It is also the most common endocrinopathy of women of reproductive